Clinical Trials Directory

Trials / Completed

CompletedNCT07301788

Donor Circadian Rhythm and Its Correlation With Prognosis After Heart Transplantation

A Mechanistic Study on the Impact of Donor Heart Procurement Time on Recipient Prognosis After Heart Transplantation Based on Multi-Omics Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn about the impact of donor heart procurement time based on circadian rhythm on the long-term outcomes of heart transplant recipients. The main question it aims to answer is: Does the time of day when a donor heart is procured-specifically during the circadian repression phase (00:00-12:00) versus the activation phase (12:00-00:00)-affect post-transplant survival and rejection rates in patients with end-stage heart failure? Patients undergoing heart transplantation at the study hospital will have leftover donor heart tissue and preservation fluid collected during surgery for multi-omics analysis. These participants will then be followed prospectively for up to three years to track survival and rejection outcomes.

Conditions

Timeline

Start date
2023-10-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-12-24
Last updated
2025-12-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07301788. Inclusion in this directory is not an endorsement.